ScienceDex / Researcher record
De, Siddhartha
- 7 Hills Pharma, LLC (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2022 | $999,300 | 1 | #9,863 |
| 2023 | $1,926,091 | 2 | #4,028 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20221 record
- FY2023 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2022 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing De, Siddhartha as a PI. Multi-PI records show the full award amount for context.
- 5R44AI172437-02R44Contact PIIntegrin activator-adjuvanted DNA vaccine against Trypanosoma cruzi infection$997.9Kaward amount
- 1R44AI176894-01R44Contact PI7HP349, an oral integrin activator to augment effectiveness of pre-exposure influenza vaccination$928.2Kaward amount
Award organization
Organizations that administered FY2023 awards listing De, Siddhartha as a PI.
FY2023 award administered by 7 Hills Pharma, LLC (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2022First NIH Award7 Hills Pharma, LLC
- 2022$500K Cumulative Funding
- 2022Entered Top 50% NationallyRanked #9863
- 2023$1M Cumulative Funding
- 2023$2M Cumulative Funding
- 2023Entered Top 25% NationallyRanked #4028